{"id":"https://openalex.org/W2095925614","doi":null,"title":"The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia.","display_name":"The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia.","publication_year":2008,"publication_date":"2008-07-01","ids":{"openalex":"https://openalex.org/W2095925614","mag":"2095925614","pmid":"https://pubmed.ncbi.nlm.nih.gov/18724539"},"language":"en","primary_location":{"id":"pmid:18724539","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18724539","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The journal of supportive oncology","raw_type":"Clinical Trial, Phase II"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Donald W Robinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330063522","display_name":"Johnson & Johnson (United States)","ror":"https://ror.org/03qd7mz70","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Donald W Robinson","raw_affiliation_strings":["Department of Health Economics and Pricing, Johnson & Johnson Pharmaceutical Services, Raritan, New Jersey, USA. Drobins4@cntus.jnj.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Economics and Pricing, Johnson & Johnson Pharmaceutical Services, Raritan, New Jersey, USA. Drobins4@cntus.jnj.com","institution_ids":["https://openalex.org/I1330063522"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008820720","display_name":"Debra F. Eisenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330063522","display_name":"Johnson & Johnson (United States)","ror":"https://ror.org/03qd7mz70","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debra F Eisenberg","raw_affiliation_strings":["Johnson & Johnson"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson","institution_ids":["https://openalex.org/I1330063522"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039180386","display_name":"David F Cella","orcid":"https://orcid.org/0000-0002-9881-4541","observed_orcids":["https://orcid.org/0000-0002-9881-4541"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David Cella","raw_affiliation_strings":["Medical Social Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Social Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ning Zhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330063522","display_name":"Johnson & Johnson (United States)","ror":"https://ror.org/03qd7mz70","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ning Zhao","raw_affiliation_strings":["Johnson & Johnson"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson","institution_ids":["https://openalex.org/I1330063522"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045881972","display_name":"Carla de Boer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330063522","display_name":"Johnson & Johnson (United States)","ror":"https://ror.org/03qd7mz70","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carla de Boer","raw_affiliation_strings":["Johnson & Johnson"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson","institution_ids":["https://openalex.org/I1330063522"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061685479","display_name":"Mark DeWitte","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330063522","display_name":"Johnson & Johnson (United States)","ror":"https://ror.org/03qd7mz70","country_code":"US","type":"company","lineage":["https://openalex.org/I1330063522"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark DeWitte","raw_affiliation_strings":["Johnson & Johnson"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johnson & Johnson","institution_ids":["https://openalex.org/I1330063522"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.254,"has_fulltext":false,"cited_by_count":47,"citation_normalized_percentile":{"value":0.86190157,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"6","issue":"6","first_page":"283","last_page":"90"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10397","display_name":"Nutrition and Health in Aging","score":0.39969998598098755,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10397","display_name":"Nutrition and Health in Aging","score":0.39969998598098755,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10231","display_name":"Pancreatic and Hepatic Oncology Research","score":0.25760000944137573,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.2029000073671341,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9610000252723694},{"id":"https://openalex.org/keywords/cachexia","display_name":"cachexia","score":0.8479999899864197},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.9509999752044678},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.8489999771118164},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8560000061988831},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.7850000262260437},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.8529999852180481},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9639999866485596},{"id":"https://openalex.org/keywords/facit-fatigue","display_name":"FACIT-Fatigue","score":0.8870000243186951},{"id":"https://openalex.org/keywords/anorexia","display_name":"anorexia","score":0.48500001430511475},{"id":"https://openalex.org/keywords/pain","display_name":"pain","score":0.6299999952316284},{"id":"https://openalex.org/keywords/karnofsky-performance-status","display_name":"Karnofsky performance status","score":0.7440000176429749},{"id":"https://openalex.org/keywords/sf-36","display_name":"SF-36","score":0.7540000081062317},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9534256458282471},{"id":"https://openalex.org/C2777704314","wikidata":"https://www.wikidata.org/wiki/Q6003455","display_name":"Cachexia","level":3,"score":0.7926614880561829},{"id":"https://openalex.org/C2780210213","wikidata":"https://www.wikidata.org/wiki/Q212961","display_name":"Pancreatic cancer","level":3,"score":0.6435417532920837},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.6346186995506287},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5597138404846191},{"id":"https://openalex.org/C2778654693","wikidata":"https://www.wikidata.org/wiki/Q254327","display_name":"Anorexia","level":2,"score":0.5012626647949219},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5009860992431641},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4996674060821533},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.4400829076766968},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4377533197402954},{"id":"https://openalex.org/C2776907518","wikidata":"https://www.wikidata.org/wiki/Q1734165","display_name":"Performance status","level":3,"score":0.41157782077789307},{"id":"https://openalex.org/C2779951463","wikidata":"https://www.wikidata.org/wiki/Q7268788","display_name":"Quality of life (healthcare)","level":2,"score":0.4100727438926697},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4027889370918274},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069285","descriptor_name":"Infliximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000964","descriptor_name":"Antimetabolites, Antineoplastic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001066","descriptor_name":"Appetite","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002100","descriptor_name":"Cachexia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002100","descriptor_name":"Cachexia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002100","descriptor_name":"Cachexia","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005221","descriptor_name":"Fatigue","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D005221","descriptor_name":"Fatigue","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D010190","descriptor_name":"Pancreatic Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D015431","descriptor_name":"Weight Loss","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017063","descriptor_name":"Outcome Assessment, Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017567","descriptor_name":"Karnofsky Performance Status","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:18724539","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18724539","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The journal of supportive oncology","raw_type":"Clinical Trial, Phase II"},{"id":"mag:2095925614","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18724539","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":54,"referenced_works":["https://openalex.org/W57379865","https://openalex.org/W99465760","https://openalex.org/W130455168","https://openalex.org/W195601543","https://openalex.org/W599204794","https://openalex.org/W1493883088","https://openalex.org/W1580118290","https://openalex.org/W1896432851","https://openalex.org/W1908242390","https://openalex.org/W1968330239","https://openalex.org/W1969092046","https://openalex.org/W1971807392","https://openalex.org/W1973687327","https://openalex.org/W1975230416","https://openalex.org/W1981187546","https://openalex.org/W1991877871","https://openalex.org/W1996177083","https://openalex.org/W1996710384","https://openalex.org/W1997155298","https://openalex.org/W2008869575","https://openalex.org/W2021061419","https://openalex.org/W2021189698","https://openalex.org/W2029445248","https://openalex.org/W2034698532","https://openalex.org/W2038962823","https://openalex.org/W2046387692","https://openalex.org/W2046822738","https://openalex.org/W2047609053","https://openalex.org/W2051814620","https://openalex.org/W2053545935","https://openalex.org/W2057518657","https://openalex.org/W2064824453","https://openalex.org/W2068008235","https://openalex.org/W2078322815","https://openalex.org/W2081573816","https://openalex.org/W2088170980","https://openalex.org/W2089524549","https://openalex.org/W2099354209","https://openalex.org/W2107954941","https://openalex.org/W2117043915","https://openalex.org/W2120629110","https://openalex.org/W2120657031","https://openalex.org/W2123857987","https://openalex.org/W2130377214","https://openalex.org/W2135475067","https://openalex.org/W2138512906","https://openalex.org/W2141317091","https://openalex.org/W2144299178","https://openalex.org/W2151260664","https://openalex.org/W2167869791","https://openalex.org/W2168293740","https://openalex.org/W2399613688","https://openalex.org/W3145192378","https://openalex.org/W4296277331"],"related_works":["https://openalex.org/W7144076440","https://openalex.org/W3006671917","https://openalex.org/W2978250267","https://openalex.org/W4409631317","https://openalex.org/W3215467562","https://openalex.org/W3007075198","https://openalex.org/W2582056630","https://openalex.org/W3126599965","https://openalex.org/W4399262399","https://openalex.org/W7134054393"],"abstract_inverted_index":{"Data":[0],"from":[1,73],"a":[2,63,174,192],"clinical":[3],"study":[4],"of":[5,43,53,77,84,190,203,215],"86":[6],"pancreatic":[7,31,217],"cancer":[8,32,218],"patients":[9,33,169,219],"with":[10,34,170,182,220],"involuntary,":[11],"significant":[12],"weight":[13],"loss":[14],"(cachexia)":[15],"were":[16,36,47,57],"used":[17],"to":[18],"explore":[19],"the":[20,74,94,158],"relationship":[21],"between":[22],"patient-reported":[23],"outcomes":[24],"(PROs)":[25],"and":[26,55,93,114,129,137,212],"survival.":[27],"In":[28],"all,":[29],"28":[30,46],"cachexia":[35],"given":[37,48,58],"gemcitabine":[38,49,59],"(Gemzar)":[39],"plus":[40,50,60],"3":[41],"mg/kg":[42,52],"infliximab":[44],"(Remicade),":[45],"5":[51],"infliximab,":[54],"30":[56],"placebo":[61],"in":[62,157],"double-blinded,":[64],"phase":[65],"II,":[66],"multicenter":[67],"trial.":[68],"PRO":[69],"endpoints":[70],"included":[71],"scores":[72,103,139],"Functional":[75,82],"Assessment":[76,83],"Chronic":[78],"Illness":[79],"Therapy-Fatigue":[80],"(FACIT-F),":[81,109],"Anorexia/":[85],"Cachexia":[86],"Therapy":[87],"(FAACT),":[88,113],"Brief":[89],"Pain":[90],"Inventory":[91],"(BPI),":[92],"Short-Form":[95],"36":[96],"general":[97],"health":[98,111,131],"survey":[99],"(SF-36).":[100],"Population":[101],"mean":[102],"at":[104],"baseline":[105,148],"indicated":[106,132],"fatigue":[107,136,172,197],"problems":[108],"nutritional":[110],"issues":[112],"mild-to-moderate":[115],"pain":[116],"(BPI":[117],"\"worst":[118],"pain\"":[119],"score).":[120],"Baseline":[121,135],"normalized":[122],"SF-36":[123],"values":[124],"for":[125,209],"physical":[126],"functioning,":[127],"vitality,":[128],"mental":[130],"substantial":[133],"impairment.":[134],"physical-functioning":[138],"predicted":[140,167],"survival":[141,178],"as":[142],"well":[143],"as,":[144],"or":[145,152,163],"better":[146],"than,":[147],"Karnofsky":[149],"Performance":[150],"Status":[151],"hemoglobin":[153],"level.":[154],"A":[155],"cut-point":[156],"FACIT-F":[159],"score":[160],"(median":[161],"<":[162],"=":[164],"30)":[165],"strongly":[166],"mortality;":[168],"greater":[171],"had":[173],"lower":[175],"median":[176],"overall":[177],"than":[179],"did":[180],"those":[181],"less":[183],"fatigue.":[184],"These":[185,222],"findings":[186],"supported":[187],"several":[188],"features":[189],"an":[191],"priori":[193],"clinical-benefit":[194],"model.":[195],"Patient-reported":[196],"provided":[198],"powerful":[199],"prognostic":[200],"information;":[201],"tracking":[202],"this":[204],"symptom":[205],"may":[206],"be":[207,225],"useful":[208],"treatment":[210],"planning":[211],"medical":[213],"monitoring":[214],"advanced-stage":[216],"cachexia.":[221],"results":[223],"must":[224],"confirmed":[226],"by":[227],"larger":[228],"trials.":[229]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}